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1181Pericardial DelayedHyperenhancementWith CMR Imaging in Patients
With Constrictive Pericarditis Undergoing Surgical Pericardiectomy
A Case Series With Histopathological Correlation
O B J E C T I V E S The purpose of this study was to examine the prevalence and histopathologic
correlates of pericardial delayed hyperenhancement (DHE) seen with cardiac magnetic resonance
imaging (CMR) among patients with constrictive pericarditis (CP) undergoing pericardiectomy.
B A C KG ROUND Constrictive pericarditis patients studied by CMR will occasionally demonstrate
ericardial DHE following gadolinium contrast administration.
METHOD S We identiﬁed 25 CP patients who underwent pericardiectomy following CMR-gadolinium
tudy. We also assessed 10 control subjects with no evidence of pericardial disease referred for cardiac
iability imaging. A novel 14-segment pericardial model was used to determine pericardial DHE score and
hickness score. Histopathology of pericardial specimens was reviewed and evaluated semiquantitatively on
4-point scale for the extent of calciﬁcation, ﬁbrosis, inﬂammation, and neovascularization.
R E S U L T S DHE was present in 12 (48%) CP patients (DHE group), and absent in 13 CP patients
DHE– group) and all control patients. The DHE group had greater ﬁbroblastic proliferation and
eovascularization, as well as more prominent chronic inﬂammation and granulation tissue. Fibroblastic
roliferation and chronic inﬂammation correlated with DHE presence quantitated by DHE score
Spearman r  0.578, p  0.002, and r  0.590, p  0.002, respectively), but not with pericardial
hickness. Segmental analysis demonstrated no signiﬁcant difference in the percentage of patients with
ifferent pericardial segmental thickness; however, overall, in each segment, the DHE group tended to
ave greater pericardial thickness.
CONC L U S I O N S The presence of pericardial DHE on CMR is common in patients with CP, and its
resence is associated with histological features of organizing pericarditis, which may be a target for
uture focused pharmacological interventions. Patients with CP without pericardial DHE had more
ericardial ﬁbrosis and calciﬁcation, as well as lesser degrees of pericardial thickening. (J Am Collardiol Img 2011;4:1180–91) © 2011 by the American College of Cardiology Foundationonstrictive pericarditis (CP) has long
posed a diagnostic challenge to the clini-
cian. Whereas the normal pericardium is a
thin, avascular sac enveloping the heart in
the anterior mediastinum, its relative inelasticity
provides constraint during diastolic filling that lim-
its chamber dilation, particularly the thin-walled
right atrium and ventricle (1). Classically, CP is
defined as an impedance to diastolic filling caused
by a fibrotic pericardium (2), with pericardiectomy,
involving partial or complete decortication, being
the treatment of choice in experienced centers.
In the past decade, with the rapid development of
several complimentary, noninvasive, cardiovascular
imaging modalities, constrictive physiology can be
more readily identified. Cardiac magnetic resonance(CMR) represents one of the most versatile nonin-
vasive imaging modalities available, offering high
spatial resolution and image contrast, along with
tissue characterization, and basic hemodynamic as-
sessment. Further, CMR does not impose ionizing
radiation exposure, which is generating greater con-
cern among both physicians and the lay public (3).
Delayed hyperenhancement (DHE) CMR has
emerged as the gold standard in the detection and
characterization of myocardial infarction and fibro-
sis in recent years (4). DHE CMR images are
acquired with an inversion recovery–prepared
gradient-echo or steady-state free-precession, im-
aging pulse sequence, with images acquired 10 to 15
min following gadolinium (Gd) chelate contrast
administration. The most commonly used Gd
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1182agents are extracellular and excluded by intact
myocardial cell membranes, but they accumulate in
areas of abnormal myocardium resulting in T1 (the
recovery of longitudinal magnetization) shortening.
This T1 shortening, in combination with an inver-
ion time set to null normal myocardium, results in
igher signal intensity on T1-weighted imaging and
improved contrast between normal and abnormal
myocardium, such as in acute myocardial infarction,
or chronic infarction.
See page 1192
Previous studies have demonstrated the diagnos-
tic and prognostic roles of myocardial DHE in
atients with ischemic heart disease (5–7), hypertro-
phic cardiomyopathy (8), inflammatory or infiltrative
cardiomyopathy (9), and dilated cardiomyopathy (10).
Myocardial DHE has also been identified in
patients suspected of having acute myocar-
ditis (11). Prior case reports and small case
series have shown that pericardial DHE
correlates with pericardial inflammation
(12–16). However, there is a paucity of data
in CP patients correlating DHE CMR and
surgical histopathology. In the present study,
we tested the hypothesis that pericardial
DHE is present in patients with CP and
correlates with histopathologic findings of
active inflammation.
M E T H O D S
Study population. Sixty-eight CP patients
were retrospectively identified who under-
ent surgical pericardiectomy at the Cleveland
linic between August 2006 and April 2010. Of
hese, 25 patients were identified who, due to
hysician referral, underwent pre-operative CMR
xamination following Gd contrast administration
nd had available surgical pathology specimen for
eview (23 men, 2 women; mean age: 59 16 years,
ange 18 to 80 years). A control group of 10
onsecutive patients (2 men, 8 women; mean age:
6 11 years, range 41 to 68 years) with no clinical
vidence of pericardial disease was referred for
yocardial viability imaging and also imaged. Clin-
cal, laboratory, and demographic data were ob-
ained from electronic medical records, and the
rotocol was approved by the local Institutional
eview Board.
CMR protocol. Digitally archived CMR studies were
s
letrospectively reviewed by 2 experienced readersM.A.B., D.H.K.), who were blinded to original
linical data, initial CMR study interpretation, and
istological findings. CMR studies were performed
n a 1.5-T magnetic resonance imaging (MRI)
canner—Achieva XR (Philips Medical Systems,
est, the Netherlands) (n  12) or an Avanto
Siemens Healthcare, Berlin, Germany) (n 
2)—or a 3.0-T MRI scanner (Trio, Siemens
ealthcare) (n  1). All imaging was performed
sing commercially available software, electrocardio-
raphic triggering, and dedicated phased-array re-
eiver coils.
Phase sensitive inversion recovery DHE imaging,
or comprehensive assessment of both pericardium
nd myocardium, was performed following the
ntravenous injection of Gd-diethylenetriamine
enta-acetic acid (0.1 to 0.2 mmol/kg body weight),
sing an inversion recovery–spoiled gradient-echo
echnique in the cardiac short-axis, vertical long-
xis, as well as 3- and 4-chamber long-axis planes.
Typical imaging parameters: 1.5-T Philips
chieva: recovery time [TR]: 6.5 ms, echo time
TE]: 3.2 ms, flip angle: 15°, matrix: 128  144,
field of view: 250 to 300  310 to 340, echo train
length: 15; 1.5-T Siemens Avanto: TR: 8.7 ms,
TE: 3.4 ms, flip angle: 25°, matrix: 156 256, field
of view: 276  340, 25 lines per segment; 3.0-T
Siemens Trio: TR: 3.1 ms, TE: 1.8 ms, flip angle:
55°, matrix: 340 255, field of view: 192 163, 15
lines per segment). Inversion time was selected for
optimal nulling of viable myocardium based on
evaluation of images obtained from an ultrafast
gradient-echo pulse sequence (Look-Locker tech-
nique), using a single short-axis slice with progres-
sively increasing inversion time (typical inversion
times were in the range of 225 to 300 ms). Post-Gd
images were obtained 8 to 15 min following injec-
tion of contrast agent. Morphologic pericardial
assessment and thickness measurements were made
using breath-hold, segmented k-space, turbo spin-
echo pulse sequences. (Typical imaging parameters:
1.5-T Philips Achieva: TR: 1500 ms, TE: 80 ms,
echo train length: 32, number of signal averages: 2,
matrix: 192  240, field of view: 330  330; 1.5-T
Siemens Avanto: TR: 2 R-R intervals, TE: 56 ms,
echo spacing: 7 ms, 15 lines per segment, number of
signal averages: 1, typical matrix: 166  256, field
of view: 293  360; 3.0-T Siemens Trio: TR: 2000
ms, TE: 60 ms, echo train length: 20, number of
signal averages: 1, matrix: 236  165, field of view:
320  320).
Continuous and categorical MRI variables in-A B B R E V I A T I O N S
A N D A C R O N YM S
CMR cardiac magnetic
resonance
CP constrictive pericarditi
DHE delayed
hyperenhancement
Gd gadolinium
hpf high power field(s)
MRImagnetic resonance
imaging
T1 recovery of longitudina
agnetization
E echo timecluded Gd contrast volume (ml), left ventricular
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1183ejection fraction (%), left ventricular end-
diastolic volume and end-systolic volume, cardiac
output (l/min), pericardial effusion, increased
pericardial thickness (4 mm), epicardial tether-
ing/diastolic restraint, interventricular septal
bounce, and tubular ventricular morphology. For
each study, only the presence or absence of
pericardial DHE and overall pericardial thickness
(4 mm or 4 mm) were based on the impres-
ion of the clinical reader at the time of the
linical study. Using a novel, 14-segment model
developed in-house) of the pericardium, 2 expe-
ienced readers reviewed the CMRs, determined
he presence or absence of DHE in each pericar-
ial segment, and performed representative peri-
ardial thickness measurements in each segment
categorized as: 2 mm, 2 to 5 mm, 5 to 10
mm, 10 mm). DHE was defined as a subjective
increase in signal intensity of the pericardium
relative to that of chest wall soft tissue. Presence
of DHE by blinded reader review was defined by
having at least 2 segments positive for DHE. A
DHE score was calculated as the sum of the
Figure 1. Imaging the Pericardium
First column is Movat pentachrome stain of pericardium. Second c
which highlights the endothelial lining of the capillaries. Panels (A)
ing pericarditis with ﬁbroplasias; (E) and (F) represent organizing pe
and (G) and (H) represent organized ﬁbrous pericarditis showing de
phase sensitive inversion recovery images, and fourth column (2, 4
delayed hyperenhancement (arrow) is represented in third column, secpericardial segments thought to contain any
DHE, with a total possible score of 14, with 1
point being given to each of the 14 segments we
included in our model.
Surgical pathology. The organization of pericardial
nflammation is a dynamic process. Organizing
ericarditis with fibroplasia (i.e., abundant prolifer-
ting fibroblast present) results in thickening of the
ericardium as a result of the presence of granula-
ion tissue and fibrinous exudates, in addition to
brosis (Fig. 1). The granulation tissue comprises a
roliferation of plump fibroblasts and capillaries
neovascularization) in an edematous stroma infil-
rated by variable amounts of lymphoplasmacytic
ells. As the inflammatory process subsides, the
rganizing pericarditis evolves to increased fibrosis
ith marked decrease of fibroblasts and inflamma-
ory cells as well as decreased vascularity. The
nd-stage result is an organized pericarditis that
xhibits densely fibrotic pericardium with varying
egrees of calcification.
Pericardial specimens were routinely formalin-
xed, paraffin-embedded, and sectioned for
n is a section of pericardium with immunostaining with CD34,
(B) represent normal pericardium; (C) and (D) represent organiz-
rditis demonstrating ﬁbrosis with organizing ﬁbrinous exudate;
ﬁbrosis with calciﬁcation (asterisk). Third column (1, 3, 5) are
is breath-hold, turbo spin-echo black-blood image. Pericardialolum
and
rica
nse
, 6)ond row, image 1.
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1184hematoxylin-eosin and Movat pentachrome stain-
ing. All specimens from the 25 surgical patients
were reviewed by 2 experienced cardiovascular pa-
thologists (C.D.T., E.R.R.). For the purpose of this
study, pathological diagnoses were categorized as
organizing pericarditis with fibroplasia, organizing
pericarditis, and organized fibrous pericarditis. In
addition, a more detailed histological assessment
included measurement of the maximal thickness
(mm) and recording for the presence or absence of
granulation tissue, fibrinous exudate, acute inflam-
mation, granulomatous inflammation, hemosiderin
deposition, and mesothelial hyperplasia. Calcifica-
tion and chronic inflammation were semiquantita-
tively graded on a 4-point scale: 0  absent; 1 
mild; 2  moderate; 3  severe. Fibroblastic
proliferation was semiquantitatively and semiquali-
tatively graded per 10 high power fields (hpf) as
follows: 0  absent; 1  few spindly fibroblasts;
2  many spindly fibroblasts; 3  many plump
reactive fibroblasts. Immunohistochemical staining
with CD34 (Cell Marque, Rocklin, California) was
performed to better assess the extent of neovascu-
larization, which was assessed as follows: 0  5
capillary profiles/hpf; 1  5 to 10 capillaries/hpf;
2  11 to 20 capillaries/hpf; 3  20 capillaries/
hpf.
Invasive hemodynamics and echocardiography. Inva-
sive cardiac hemodynamics were obtained by review
of the electronic medical record. Continuous vari-
ables included right atrial mean pressure (mm Hg),
pulmonary capillary wedge pressure (mm Hg), left
ventricular end-diastolic pressure (mm Hg), and
pulmonary artery mean pressure (mm Hg).
Digitally archived, echocardiographic recordings
were sequentially reviewed by a single, experienced
cardiologist (A.O.Z.). Categorical variables in-
cluded pericardial effusion (present or absent), in-
ferior vena cava plethora (defined as 2 cm in
diameter) and interventricular diastolic septal
bounce. Continuous variables included percentage
respiratory change in mitral pulse-wave Doppler
early (E) inflow (% from expiration) and septal and
lateral annular early (e=) velocities and E/e=.
Statistical analysis. Continuous variables are pre-
ented as mean  SD and as 25th, 50th (median),
nd 75th percentiles, when the variable is skewed.
omparisons were made using Wilcoxon rank sum
ests and Kruskal-Wallis test if more than 2 groups
xisted. Categorical data are described using fre-
uencies and percentages. Comparisons were made
sing Fisher exact tests. All analyses were per-
ormed using SAS statistical software (version 9.1, DAS Institute Inc., Cary, North Carolina). Uncer-
ainty is expressed by 95% confidence limits. Spear-
an correlation was used to measure relation of
HE severity quantitated by DHE score and peri-
ardial thickness with histopathologic variables.
greement between the readers for the segmental
ericardial DHE was assessed with Cohen kappa
nd with Spearman rho for the DHE index. Values
f p  0.05 were considered statistically significant.
R E S U L T S
Patient characteristics. Of 25 patients who under-
went pericardiectomy with pre-operative CMR ex-
amination with intravenous Gd contrast (surgical
group), pericardial DHE was present in 12 (48%).
DHE was absent in 13 CP patients (DHE– group)
and in all control patients. Patients were well
matched by age: DHE (58  18 years), DHE–
(60  15 years), control (56  11) (p  0.36)
(Table 1). However, there were significantly more
women in the control group (8 of 10 [80%]) than in
the surgical group (2 of 25 [8%], p  0.0001 for
both) and more Caucasians in the surgical group
(24 of 25 [92%]) than in the control group (8 of 10
[80%], p  0.08 for both). In addition, more
patients in the DHE– group were New York Heart
Association functional class III (DHE: 7 of 12
[58%]; DHE–: 9 of 13 [69%]; control group: 1 of
10 [10%]; p 0.0079). The most common etiology
of CP was idiopathic (67% DHE, 62% DHE–).
Four patients (33%) in the DHE group and 3
patients (23%) in the DHE– group had undergone
prior cardiac surgery (coronary revascularization,
valve repair/replacement). Univariate unadjusted
comparisons of all surgical patients showed that
there were no statistically significant differences in
demography and medical history between these 2
groups. Compared with the control group, there
was a significantly greater number of patients with
prior episodes of clinical pericarditis among the
surgical group (15 of 25 [60%] vs. 0 of 10 [0%], p
0.005). Although there was a trend toward greater
nonsteriodal anti-inflammatory drug use among
DHE patients, overall medication use at time of
CMR (within 1 week) was not significantly differ-
ent between groups.
CMR with inter-rater agreement. The median time
rom pre-operative CMR to surgery in the DHE
roup was 42 days (range 1 to 150 days), and in the
HE– group, it was 27 days (range 2 to 157 days,
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1185p 0.4 for both) (Table 2). Pericardial thickness4
m, epicardial tethering/diastolic restraint, inter-
entricular septal bounce, and tubular-shaped ven-
ricles were more common among surgical patients
ompared with controls (Table 1). Inferior vena
ava size by CMR in DHE and DHE– patients
as 33  6 and 31  5 (p  0.48), respectively.
None of the patients in the surgical (DHE and
Table 1. Patient Characteristics at Baseline
Sur
DHE (n  12)
Demographics
Age, yrs 58 18
Female sex 2 (17)
Race
Caucasian 11 (100)
African American 0 (0)
Other 0 (0)
NYHA functional class
I 4 (33)
II 1 (8)
III 7 (58)
BNP,‡ 25th/median/75th 148/198/237
Comorbidities
CKD, GFR 60 1 (8.3)
History of chest trauma 0 (0)
Prior cardiac surgery 4 (33)
Neoplasia 0 (0)
Pericarditis 7 (58)
Immunologic condition 2 (17)
MRI outcomes/characteristics
MRI pericardial effusion 6 (50)
MRI pericardial thickness, 4 mm 9 (75)
MRI epicardial tethering/diastolic restraint 11 (92)
MRI septal bounce 12 (100)
MRI tubular ventricle 11 (92)
CMR IVC size, mm 33 6
CMR LVEF, % 58 8.6
CMR EDV, cc 121 32
CMR ESV, cc 53 22
CMR cardiac output, l/min 5.3 1.0
Medication at time of MRI
None 4 (33)
ASA 7 (58)
DMARD 1 (8.3)
NSAID 3 (25)
Steroid 1 (8.3)
Values are presented as n (%) or mean  SD unless otherwise indicated. Bold
*Comparison between DHE group (n  12) and DHE– group (n  13). †Compa
are missing for 4 patients in the DHE group and 6 patients in the DHE– grou
ASA  aspirin; BNP  brain natriuretic peptide; CKD  chronic kidney d
hyperenhancement; DHE–  without pericardial delayed hyperenhancement; D
end-systolic volume; GFR glomerular ﬁltration rate; IVC inferior vena cava; LV
nonsteroidal anti-inﬂammatory drug; NYHA  New York Heart Association.HE–) group had concomitant myocardial disease. there was a trend toward more common pericardial
ffusion among the DHE group (6 of 12, 50%)
ompared with the DHE– group (3 of 13, 23%);
owever, this did not reach statistical significance
p  0.23). The left ventricular ejection fraction
nd cardiac output were both significantly lower,
nd the end-diastolic and end-systolic volumes
ere both significantly higher among control pa-
l Group
Control Group (n  10)E– (n  13) p Value* p Value†
60 15 0.74 56 11 0.36
0 (0) 0.22 8 (80) <0.0001
13 (100) 1.0 8 (80) 0.08
0 (0) 1.0 1 (10) 0.29
0 (0) 1.0 1 (10) 0.29
0.61 0.0079
2 (15) 4 (40)
2 (15) 5 (50)
9 (69) 1 (10)
6/115/138 0.0065 — —
3 (23) 0.59 0 (0) 0.30
2 (15) 0.48 0 (0) 0.9
3 (23) 0.67 1 (10) 0.39
1 (7.7) 0.9 0 (0) 0.9
8 (62) 0.9 0 (0) 0.0016
1 (7.7) 0.59 1 (10) 0.9
3 (23) 0.23 2 (20) 0.45
12 (92) 0.32 0 (0) <0.0001
11 (85) 0.9 0 (0) <0.0001
13 (100) 1.0 0 (0) <0.0001
11 (85) 0.9 0 (0) <0.0001
31 5 0.48 — —
53 6.8 0.15 33 16 0.0005
142 25 0.19 202 51 0.0007
67 17 0.07 138 56 0.0003
5.3 1.1 0.9 4.8 1.8 0.44
6 (46) 0.69 4 (40) 0.9
5 (38) 0.43 5 (50) 0.9
1 (7.7) 0.9 0 (0) 0.9
1 (7.7) 0.32 0 (0) 0.30
2 (15) 0.9 1 (10) 0.9
values are statistically signiﬁcant, and dashes indicate data are not available.
between surgical group (n  25) and nonsurgical group (n  10). ‡BNP values
e; CMR  cardiac magnetic resonance; DHE  with pericardial delayed
 disease-modifying antirheumatic drug; EDV  end-diastolic volume; ESV 
left ventricular ejection fraction; MRImagnetic resonance imaging; NSAIDgica
DH
9
face
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iseas
MARD
EFients, as would be expected in this patient popula-
apilla
as in Table 1.
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1186tion with predominantly ischemic cardiomyopathy
referred for viability assessment.
Segmental CMR analysis showed that for each
segment, both blinded readers agreed with the
initial reader regarding determined groups (DHE
Table 2. Surgical Patient Invasive Hemodynamic Characteristics
DHE (n 
n* Me
Interval (catheterization to surgery), months 9 1.
RA mean pressure, mm Hg 9
PCW mean pressure, mm Hg 8
LVED pressure, mm Hg 8
PA mean pressure, mm Hg 8
*Data available.
LVED  left ventricular end-diastolic; PA  pulmonary artery; PCW  pulmonary c
greement (Cohen Kappa) Between Reader #1 and Reader #2, by
Inter-Rater
Agreement (Kappa)
Overall (n  35)
0.68
0.85
0.62
0.82
0.60
0.67
0.61
0.66
0.82
0.71
0.71
0.52
–0.04
0.25
0.66
0.69
en kappa) between Reader #1 and Reader #2, by segment (left). Using a 14-seg
d CMRs and determined presence or absence of DHE in each pericardial segm
for all 14 segments were summed to arrive at total DHE score. In addition, re
to 10 mm, 10 mm) were performed by each reader using corresponding viand DHE–) (Table 3). Segmental analysis demon-
strated no significant difference in the percentage of
patients with different pericardial segmental thick-
ness; however, overall, in each segment, the DHE
group tended to have greater pericardial thickness.
Surgical
) DHE- (n  13)
 SD n* Mean  SD p Value
6.1) 9 3.1 (7 days–15 months) 0.13
4 9 21 3 0.09
4 9 25 6 0.075
4 8 25 5 0.11
5 9 33 7 0.11
ry wedge; RA  right atrial; other abbreviations as in Table 1.
ment
t model (developed in-house) of the pericardium (right), two experienced,
Each segment was assessed for DHE and assigned a binary score (0  DHE–,
entative pericardial thickness measurements in each segment (categorized
on T2-weighed turbo spin-echo images without fat-saturation. Abbreviations12
an
1 (0–
17
20
21
28Table 3. Inter-Rater A Seg
Segment
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Overall
Segments 1–12 only
Inter-rater agreement (Coh men
blinded readers rereviewe ent.
1  DHE). Total scores pres
as: 2 mm, 2 to 5 mm, 5 ews
b
m
a
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1187Of note, compared with the original MRI interpre-
tation, both blinded readers noted a few patients in
the DHE– group as having some segments with
DHE. Overall, there was moderate inter-rater
agreement using Cohen kappa (k  0.66) (Table 3)
etween Reader #1 and Reader #2. However, seg-
ental analysis demonstrated a moderate to strong
greement between readers (k 0.69, range 0.52 to
.85) when only segments 1 through 12 (short-axis
iews) were included. DHE score showed a strong
greement between readers (Spearman rho  0.82,
 0.001).
Surgical pathology. Pathological evaluation of the
pericardium in 25 surgical patients revealed orga-
nizing pericarditis with fibroplasia being far more
common among the DHE group (9 of 12 [75%]
vs. 2 of 13 [15%], p  0.005) and organized fibrous
pericarditis being the predominant diagnosis among
the DHE– group (8 of 13 [62%], p 0.041) (Table 4).
Accordingly, significant neovascularization (20
capillaries/hpf) was notably more common among
patients in the DHE group (4 of 12 [33%] vs. 0
of 13 [0%], p  0.039) (Figs. 1 and 2). There was
a trend toward absence of pericardial calcification (9
of 12 [75%] vs. 5 of 13 [38%], p  0.11) and mild
to severe chronic inflammation (moderate: 3 of 12
[25%] vs. 1 of 13 [7.7%], p  0.32; severe: 3 of 12
[25%] vs. 0 of 13 [0%], p  0.096) among DHE
group. No cases were diagnosed as normal pericar-
dium, nor were there cases of neoplastic or infec-
tious etiology. Fibroblastic proliferation and
chronic inflammation correlated with DHE quan-
titated by DHE score (Spearman r  0.578, p 
0.05, and r 0.590, p 0.05, respectively), but not
with pericardial thickness.
Invasive hemodynamics and echocardiography. Inva-
sive hemodynamic data were available in 69% of
DHE– patients and 75% of DHE patients. There
was a trend toward higher right atrial mean pres-
sure, pulmonary capillary wedge mean pressure, and
left ventricular end-diastolic and pulmonary artery
mean pressure in the DHE patient group com-
pared with mean pressures in the DHE– group,
though this did not reach statistical significance
(Table 2). The average time from catheterization to
surgery was 1.1 months (range 0 to 6.1 months)
among the DHE patient group and 3.1 months
(range 7 days to 15 months) among the DHE–
patient group.
The DHE patients had a significantly higher
rate of pericardial effusion on pre-operative trans-
thoracic echocardiography (DHE: n  8
67%]; DHE–: n  3 [23%], p  0.05). Themedian time from pre-operative echocardiogram
to surgery in the DHE group was 13 days
(range 2 to 70 days), and in the DHE– group was
10 days (range 2 to 68 days). Percentage respira-
tory change in pulse-wave Doppler early mitral
inflow was increased in DHE patients (26 
30%) versus DHE– patients (17  17%, p 
0.39). Average inferior vena cava size was in-
creased among nearly all surgical patients (2.58 
0.38 cm DHE patients; 2.75  0.52 cm DHE–
patients, p  0.42) and interventricular septal
bounce was noted frequently (8 of 12 [67%]
DHE patients; 12 of 13 [92%] DHE– patients,
p  0.11). The average E/e= was not different
etween groups. There was no difference in the
Table 4. Histopathologic Difference Between DHE and Non-DHE
Surgical
DHE
(n  12)
D
(n
Normal 0 (0) 0
Organizing pericarditis with ﬁbroplasia 9 (75) 2
Organizing pericarditis 1 (8.3) 3
Organized ﬁbrous pericarditis 2 (17) 8
Calciﬁcation
Absent 9 (75) 5
Mild 1 (8.3) 2
Moderate 0 (0) 1
Severe 2 (17) 5
Neovascularization
5 capillary lumina/hpf 2 (17) 6
5 to 10 capillary lumina/hpf 1 (8.3) 3
11 to 20 capillary lumina/hpf 5 (42) 4
20 capillary lumina/hpf 4 (33) 0
Fibroblasts Movat
Absent 2 (17) 8
Few spindly 1 (8.3) 3
Many spindly 3 (25) 2
Many plump 6 (50) 0
Chronic inﬂammation
Absent 3 (25) 8
Mild 3 (25) 4
Moderate 3 (25) 1
Severe 3 (25) 0
Acute inﬂammation 1 (8.3) 0
Granulation tissue 9 (75) 4
Fibrinous exudate 7 (58) 4
Hemosiderin deposition 6 (50) 2
Mesothelial hyperplasia 0 (0) 1
Thickness 4.6 1.4 3.1
Values are n (%) or mean  SD.Surgical Groups
HE
 13)
p
Value
(0) 0.011
(15) 0.0048
(23) 0.59
(62) 0.041
(38) 0.11
(15) 0.9
(7.7) 0.9
(38) 0.34
(46) 0.20
(23) 0.59
(31) 0.69
(0) 0.039
(62) 0.041
(23) 0.59
(15) 0.64
(0) 0.0052
(62) 0.11
(31) 0.9
(7.7) 0.32
(0) 0.096
(0) 0.48
(31) 0.047
(31) 0.24
(15) 0.097
(7.7) 0.9
 1.7 0.021hpf  high powered ﬁeld; other abbreviations as in Table 1.
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1188mean septal E/e= between the DHE and DHE–
roups (8 3 vs. 7 3; p 0.41) and mean lateral
E/e= (8  3 vs. 7  4; p  0.27).
D I S C U S S I O N
Our study is the largest cohort to date demon-
strating that the presence of pericardial DHE on
CMR occurs commonly in patients with CP and
that presence is associated with histological
markers of chronic inflammation and increased
neovascularization.
CMR. Segmental analysis demonstrated no signifi-
ant difference in the percentage of patients with
ifferent pericardial segmental thickness; however,
verall in each segment, the DHE group tended
o have greater pericardial thickness, suggesting
hat, though associated with DHE, increased peri-
Figure 2. Surgical Pathology Semiquantitative Comparison Betw
Statistically signiﬁcant increase in ﬁbroblasts, chronic inﬂammation,
patients with pericardial delayed hyperenhancement (DHE) compardial thickness is not necessarily confined or Hocalized to any particular segment. Histological
ndings suggest that the presence of pericardial
HE is an indicator of chronic pericardial inflam-
ation. Additionally, the presence of increased
eovascularization and fibroblast proliferation asso-
iated with pericardial DHE, as well as the trend
oward greater granulation tissue, might provide
nsight into the etiology of Gd contrast agent
ccumulation within the pericardium, as both ab-
ormal regional vascular permeability and expanded
xtracellular space can lead to pericardial DHE.
Common CMR metrics suggesting constrictive
hysiology, including pericardial thickness (4 mm),
picardial tethering/diastolic restraint, interventricular
eptal bounce, and ventricular deformation were all
tatistically more frequent among surgical patients
ompared with control patients, which might support
heir usefulness in identification of patients with CP.
DHE and DHE– Groups
vascularization, and more prominent granulation tissue among
with those without DHE (DHE–).een
neo
aredowever, clinicians and surgeons were not blinded to
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1189this information prior to treatment, and this may
alternatively reflect the incorporation of CMR data
into clinical management.
Overall, there was moderate inter-rater agree-
ment between readers #1 and #2 (k  0.66), which
improved mildly when only segments 1 through 12
were included (k  0.69). This finding is likely a
eflection of the current subjective nature of diag-
osing pericardial DHE. Additionally, with regard
o inter-rater agreement on segmental DHE, the
oderate agreement noted at the segmental level,
ut overall strong agreement with DHE score,
ould be due to different classification of segmental
ocation of DHE between the readers. A quantita-
ive approach toward defining DHE was consid-
red, though ultimately not pursued, as there is
nsufficient statistical validity to the approach. Spe-
ifically, the combination of a relatively thin struc-
ure (pericardium) and limited spatial resolution
nsures that regions-of-interest drawn will have a
mall number of pixels, and be affected by volume
veraging of edge pixels, thereby diminishing accu-
acy, particularly in cases of normal to only mildly
hickened pericardium.
Surgical pathology. The phenomenon of pericardial
HE seen in patients with pericardial disease with
istopathologic correlation has only rarely been
escribed in the medical literature (11–15). Ha et
l. (12) reported a case of tuberculous pericarditis in
hich DHE CMR imaging demonstrated promi-
ent DHE localized at the visceral and parietal
ericardium. Subsequent pathology revealed severe
nflammation with granuloma and caseous necrosis.
elgec et al. (11) reported pericardial enhancement
n 9 patients among a group of 20 patients exam-
ned with CMR, all of whom had clinically sus-
ected acute myocarditis, suggesting that myoperi-
arditis is a common presentation. Whereas 5
atients in their study underwent endomyocardial
iopsy, all with normal findings, none of these
atients had pericardial tissue obtained for histo-
ogical assessment. Thus, direct correlation with
istology was lacking. Our DHE protocol was
irected toward a comprehensive assessment of
oth myocardium and pericardium on post-contrast
HE images, and we had no cases where there was
uspected myopericarditis.
Taylor et al. (13) published the sole case series
ooking at DHE in patients with possible pericar-
ial disease. In their cohort, 16 patients with
linical suspicion of pericardial disease underwent
MR with DHE imaging, along with a controlroup of 12 patients with no clinical evidence of tpericardial disease. Only 5 of 16 patients (31%)
demonstrated pericardial DHE on MRI and were
diagnosed with inflammatory pericarditis by 1 of 3
experienced cardiovascular MR imagers who were
blinded to the histological findings. Of these 5
patients, histological diagnosis was subsequently
reported to be acute bacterial pericarditis in 1,
tubercular pericarditis in 2, and chronic inflamma-
tory pericarditis in 2. All 5 patients with DHE were
also shown to have thickened pericardial layers (4
mm). Sensitivity and specificity of 100% for detec-
tion of pericardial inflammation using DHE CMR
was reported when compared with pericardial his-
tology. In addition, 6 patients with histological
diagnosis of chronic fibrosing pericarditis demon-
strated evidence of thickened pericardium, but nei-
ther DHE nor pericardial effusion were indicated
on MRI.
Invasive hemodynamics and echocardiography. Inva-
sive hemodynamics demonstrated that both groups
had elevated filling pressures that were not statisti-
cally different (Table 2). Further, similar to CMR
findings, echocardiography showed evidence of annu-
lus paradoxus (17) with relatively decreased E/e= and
that pericardial effusion was more common among
DHE patients, which is likely a consequence of
increased vascular permeability associated with statis-
tically increased neovascularization in this group.
Study limitations. A primary limitation of our study
s the modest number of patients. Selection bias is
lso a potential. Whereas medication use at the time
f MRI was known, use between MRI and surgery
s not known and might have had an impact.
dditionally, control patients were not matched for
ex.
Pericardial enhancement intensity, as analyzed in
his investigation, is a subjective metric dependent
n several factors including timing of imaging after
d contrast administration, dose of Gd, inversion
ime chosen for imaging, and coil separation dis-
ance. Magnetic field heterogeneities and incom-
lete tissue nulling can lead to variation in image
nterpretation as well. Further, differences in renal
unction can alter the uptake of Gd contrast agent
n the interstitial space and elimination from the
ntravascular space, both of which will influence the
ontrast and signal intensity values measured in
HE-CMR.
CMR has excellent spatial resolution; however,
easurement of pericardial thickness remains a
hallenge, given the relatively small dimensions
ssociated with measuring a structure as thin as
he pericardium. The slice thickness used might
H
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1190result in significant volume averaging as well;
however, imaging planes were selected such that
the pericardium was perpendicular to the plane
whenever possible. In the future, higher resolu-
tion scans may be advantageous to more accu-
rately assess a structure as thin as the pericardium
to limit the potential for partial volume averaging
artifacts. Additionally, although our evaluation
did not routinely include short tau inversion
recovery images, which have been previously
reported to demonstrate “edema-weighted” im-
ages (18), routine use of this imaging modality in
the future might be useful during evaluation for
pericardial inflammation. Nonetheless, despite
several technical challenges, inter-rater agree-
ment was moderate in this study for pericardial
DHE and thickness measurements.
Lastly, although pericardial segmentation for
purposes of our analysis was standardized, we were
unable to directly correlate imaging segmentation to
the precise locations of surgical specimens in this
analysis.
Clinical implications. Constrictive pericarditis re-
mains a challenging diagnosis for the clinician.
Through the implementation of CMR, and specif-
ically DHE imaging, we are now better able to
delineate the histopathology associated with this
not uncommon CMR finding in patients with CP.
Whereas this investigation is hypothesis generating,
it also may help to provide insight into the medical
and surgical management of this difficult patient
population. Further, the correlation between DHE
and histopathologic inflammation demonstrated in
our study might prove useful in the management of
patients with symptomatic inflammatory pericardi-
tis (19,20). Studies evaluating interleukin-1 recep-
tor antagonist, tumor necrosis factor receptor, ma-
trix metalloproteinase activation, transformingdiol 2010;7:351–9. hyperenhancementdial steroid deposition might help elucidate the role
that termination of the inflammatory response has
on patient outcomes with constrictive pericarditis.
In the future, trials evaluating the interval change in
pericardial DHE among patients with recurrent or
transient CP with correlation to clinical symptoms
might better elucidate the precise timing of changes
in medication dosing.
C O N C L U S I O N S
The presence of pericardial DHE on CMR is
common in patients with CP. Our data suggest that
pericardial DHE is correlated with greater fibro-
blastic proliferation, chronic inflammation, and
neovascularization, which is indicative of an ongo-
ing, dynamic active inflammatory reaction. Patients
with CP without pericardial DHE had more peri-
cardial fibrosis and calcification, and lesser degrees
of pericardial thickening. Further, progressively
more chronic forms of organized fibrous pericardi-
tis, though statistically more common among pa-
tients without pericardial DHE, were not unique to
this patient population. This finding reflects that
pericardial inflammation is a dynamic process and
might be a target for focused pharmacological
interventions. Additionally, although ours is a
proof-of-concept study, larger, prospective stud-
ies, potentially incorporating T2-weighted spin-
echo imaging sequences with fat-saturation and
serum markers of inflammation (ultrasensitive
C-reactive protein, Westergren sedimentation
rate) are necessary to confirm and expand the
current study findings.
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